|Articles|September 14, 2015

Evolving Paradigms

  • Squamous NSCLC
  • Volume 1
  • Issue 1

Evolving Paradigms in Squamous NSCLC: Conclusion

Author(s)Staff Writer

Squamous cell lung cancer represents a distinct molecular pathologic NSCLC with unmet therapeutic needs, especially after failure of first-line platinum-based doublet chemotherapy.

This article is Part III of a series. View parts I and II:Evolving Paradigms in Squamous NSCLC> >

Articles in this issue


Latest CME